Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Toschi · SciRah

Researcher profile · Semantic Scholar

L. Toschi

Share profile

L. Toschi — researcher profile on SciRah

h-index: 35
Works: 135
Citations: 5,963

Most-cited papers

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
M. Infante, S. Cavuto, F. Lutman, Eliseo Passera +20 more
2015American Journal of Respiratory and Critical Care Medicine325 citations
Semantic Scholar
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.
E. Lopci, I. Grassi, A. Chiti, C. Nanni +6 more
2014American Journal of Nuclear Medicine and Molecular Imaging184 citations
Semantic Scholar
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
L. Landi, F. D’Incà, A. Gelibter, R. Chiari +17 more
2019Journal of Immunotherapy for Cancer153 citations Open access
Semantic Scholar
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery
E. Lopci, L. Toschi, F. Grizzi, D. Rahal +12 more
2016European Journal of Nuclear Medicine and Molecular Imaging145 citations
Semantic Scholar
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
F. Facchinetti, G. Mazzaschi, F. Barbieri, F. Passiglia +37 more
2020European Journal of Cancer135 citations Open access
Semantic Scholar
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.
F. Cappuzzo, G. Tallini, G. Finocchiaro, R. Wilson +11 more
2010Annals of Oncology80 citations Open access
Semantic Scholar
Hyperprogressive Disease in Patients with Non–Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of 18F-FDG PET/CT
A. Castello, S. Rossi, E. Mazziotti, L. Toschi +1 more
2019Journal of Nuclear Medicine78 citations Open access
Semantic Scholar
Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease
L. Toschi, G. Finocchiaro, Teresa T. Nguyen, M. Skokan +12 more
2014PLoS ONE76 citations Open access
Semantic Scholar
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.
F. Grossi, C. Genova, L. Crinò, A. Delmonte +18 more
2019European Journal of Cancer67 citations
Semantic Scholar
Prognostic and predictive value of MET deregulation in non-small cell lung cancer.
G. Finocchiaro, L. Toschi, L. Gianoncelli, Marina Baretti +1 more
2015Annals of Translational Medicine59 citations
Semantic Scholar
Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors
S. Rossi, L. Toschi, A. Castello, F. Grizzi +2 more
2017European Journal of Nuclear Medicine and Molecular Imaging57 citations
Semantic Scholar
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
A. Passaro, A. Prelaj, L. Bonanno, M. Tiseo +17 more
2019Clinical Lung Cancer56 citations
Semantic Scholar
Clinical implications of MET gene copy number in lung cancer.
L. Toschi, F. Cappuzzo
2010Future Oncology54 citations
Semantic Scholar
Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients.
F. De Rose, L. Cozzi, P. Navarria, A. Ascolese +8 more
2016Clinics in oncology49 citations
Semantic Scholar
The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors
A. Castello, L. Toschi, S. Rossi, E. Mazziotti +1 more
2020Journal of Cancer Research and Clinical Oncology45 citations Open access
Semantic Scholar
Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come
L. Toschi, S. Rossi, G. Finocchiaro, A. Santoro
2017ecancermedicalscience42 citations Open access
Semantic Scholar
Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors
A. Castello, F. Carbone, S. Rossi, S. Monterisi +3 more
2020Cancers37 citations Open access
Semantic Scholar
The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art.
D. Franceschini, F. De Rose, S. Cozzi, C. Franzese +5 more
2020Critical reviews in oncology/hematology37 citations
Semantic Scholar
Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors
A. Castello, S. Rossi, L. Toschi, E. Lopci
2021Journal of Clinical Medicine36 citations Open access
Semantic Scholar
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
G. Metro, B. Ricciuti, R. Chiari, Marina Baretti +9 more
2016Lung Cancer35 citations
Semantic Scholar
Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters
A. Castello, S. Rossi, L. Toschi, L. Mansi +1 more
2020Cancers34 citations Open access
Semantic Scholar
Impact of Exon 19 Deletion Subtypes in EGFR‐Mutant Metastatic Non–Small‐Cell Lung Cancer Treated With First‐Line Tyrosine Kinase Inhibitors
S. Rossi, L. Toschi, G. Finocchiaro, V. Di Noia +6 more
2019Clinical Lung Cancer30 citations
Semantic Scholar
Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy.
G. Veronesi, N. Navone, P. Novellis, E. Dieci +6 more
2020Lung Cancer28 citations
Semantic Scholar
Alectinib as neoadjuvant treatment in potentially resectable stage III ALK-positive NSCLC: Final analysis of ALNEO phase II trial (GOIRC-01-2020-ML42316).
A. Leonetti, Luca Boni, L. Gnetti, D. Cortinovis +16 more
2025Journal of Clinical Oncology27 citations Open access
Semantic Scholar
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
M. Bersanelli, S. Buti, D. Giannarelli, A. Leonetti +48 more
2020Lung Cancer26 citations Open access
Semantic Scholar
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
A. Luciani, A. Marra, L. Toschi, D. Cortinovis +18 more
2020Clinical Lung Cancer25 citations
Semantic Scholar
Immunotherapy in non-small-cell lung cancer: potential predictors of response and new strategies to assess activity.
S. Rossi, A. Castello, L. Toschi, E. Lopci
2018Immunotherapy23 citations
Semantic Scholar
Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1
A. Castello, S. Rossi, L. Toschi, E. Lopci
2020Frontiers in Oncology22 citations Open access
Semantic Scholar
Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancer
A. Castello, F. Grizzi, L. Toschi, S. Rossi +5 more
2018Nuclear medicine communications22 citations
Semantic Scholar
Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancer.
S. Rossi, L. Toschi, G. Finocchiaro, A. Santoro
2020Immunotherapy21 citations
Semantic Scholar
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer.
S. Rossi, G. Finocchiaro, V. Di Noia, M. Bonomi +10 more
2019Future Oncology20 citations
Semantic Scholar
Impact of biomarkers on non-small cell lung cancer treatment
L. Toschi, F. Cappuzzo
2010Targeted oncology20 citations
Semantic Scholar
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer
F. Grizzi, A. Castello, Dorina Qehajaj, L. Toschi +9 more
2019Cancer Immunology and Immunotherapy14 citations
Semantic Scholar
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review.
M. Abbate, D. Cortinovis, M. Tiseo, T. Vavalà +5 more
2019Future Oncology13 citations
Semantic Scholar
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results.
F. Lococo, A. Cancellieri, M. Chiappetta, A. Leonetti +15 more
2023Clinical Lung Cancer12 citations Open access
Semantic Scholar
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy.
A. Castello, L. Toschi, S. Rossi, G. Finocchiaro +5 more
2019Clinical Lung Cancer11 citations
Semantic Scholar
P3.02b-045 Patritumab plus Erlotinib in EGFR Wild-Type Advanced Non–Small Cell Lung Cancer (NSCLC): Part a Results of HER3-Lung Study: Topic: EGFR Clinical
Luis Paz-Arez, P. Serwatowski, A. Szczesna, J. Pawel +8 more
201711 citations Open access
Semantic Scholar
Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapy.
S. Monterisi, A. Castello, L. Toschi, D. Federico +3 more
2019American Journal of Nuclear Medicine and Molecular Imaging9 citations
Semantic Scholar
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC.
S. Rossi, P. Damiano, L. Toschi, G. Finocchiaro +5 more
2021Current Problems in Cancer8 citations
Semantic Scholar
Immunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience.
A. Luciani, L. Toschi, S. Fava, D. Cortinovis +12 more
2018Annals of Oncology8 citations Open access
Semantic Scholar
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
F. Pessina, P. Navarria, L. Cozzi, S. Tomatis +8 more
2017British Journal of Radiology8 citations Open access
Semantic Scholar
Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis
E. Lopci, F. Grizzi, Carlo Russo, L. Toschi +5 more
2017Nuclear medicine communications8 citations
Semantic Scholar
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
A. Prelaj, M. Ganzinelli, L. Provenzano, L. Mazzeo +62 more
2023Clinical Lung Cancer7 citations Open access
Semantic Scholar
Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung Cancer
Sabrina Rossi, Silvia Masini, G. Finocchiaro, E. Lorenzi +2 more
2024Cancers6 citations Open access
Semantic Scholar
Spindle Cell Nuclear in Testis Carcinoma of the Lung: A Challenging Tumor.
G. Pelosi, M. Cannone, E. Balladore, D. Rahal +7 more
2019Journal of Thoracic Oncology6 citations Open access
Semantic Scholar
Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?
S. Rossi, G. Finocchiaro, S. Marchetti, L. Toschi +1 more
2018Immunotherapy6 citations
Semantic Scholar
989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)
M. Awad, G. Pelizzari, J. Stevenson, M. M. Tarruella +16 more
2022Annals of Oncology5 citations Open access
Semantic Scholar
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer.
V. Gregorc, L. Mazzarella, C. Lazzari, P. Graziano +22 more
2021Clinical Lung Cancer5 citations
Semantic Scholar
How to detect illegal waste shipments? The case of the international trade in polyethylene waste
R. Pittiglio, F. Reganati, L. Toschi
20175 citations
Semantic Scholar
Well-being, Landscape and Sustainability of Communication
Eugenio Pandolfini, Arrate Cia Bemposta, Marco Sbardella, Gianluca Simonetta +1 more
20165 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Rossi×21
Invite
S. Rossi — researcher profile on SciRah
G. Finocchiaro×16
Invite
G. Finocchiaro — researcher profile on SciRah
E. Lopci×15
Invite
E. Lopci — researcher profile on SciRah
A. Santoro×12
Invite
A. Santoro — researcher profile on SciRah

×12

Invite

A. Castello — researcher profile on SciRah

Invite

M. Tiseo — researcher profile on SciRah

Invite

M. Alloisio — researcher profile on SciRah

Invite

F. Grizzi — researcher profile on SciRah

M. Scorsetti×5

Invite

M. Scorsetti — researcher profile on SciRah

Invite

M. Roncalli — researcher profile on SciRah

Invite

D. Rahal — researcher profile on SciRah

Invite

C. Proto — researcher profile on SciRah